Please login to the form below

Not currently logged in
Email:
Password:

Lonza to buy Arch Chemicals for $1.4bn

Life science industry suppliers, Lonza, are to acquire outstanding shares of biocides company Arch Chemicals for $47.20 per share – around $1.4bn in total

Life science industry suppliers, Lonza, are to acquire outstanding shares of biocides company Arch Chemicals for $47.20 per share – around $1.4bn in total.

A tender offer has been agreed between the two companies, subject to conditions including clearance from antitrust regulatory authorities.

Switzerland-based Lonza said it expects to commence the tender offer by July 15, 2011 and to complete the tender offer later in 2011.

According to the company, once the transaction is complete, Lonza will have the world's leading microbial control business, with related products being used in such areas as water treatment, hygiene and materials protection.

The micriobial market is estimated to have a global value of around $10bn, and a growth rate of four to six per cent every year.

Stefan Borgas, CEO of Lonza, said: "Lonza and Arch Chemicals offer highly complementary products and technologies and together will be the global leader in controlling unwanted microbes. The business will enjoy a strong platform for accelerated future growth for the benefit of all our stakeholders."

12th July 2011

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Apex.co.uk Conferences, Events and Exhibition Stands

Apex.co.uk is one of the UK’s leading event and exhibition agencies, specialising in healthcare. We understand your communication goals, whether...

Latest intelligence

Big data, privacy and the rise of genomic testing
Blue Latitude Health speaks to Johan Christiaanse, Marketing Director at BGI, to find out how the medical profession can overcome one of the major barriers to precision medicine – big...
Deal Watch January 2018
...
Emotional Intelligence and Blended Learning in Healthcare
...

Infographics